Arvaya Healthcare Closes Trading Window for Q2/H1 FY27 Results

Arvaya Healthcare Ltd has announced the closure of its trading window for directors, promoters, key managerial personnel, and designated persons. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the second quarter and half year ending September 30, 2026. In line with SEBI regulations, the PAN of designated persons and their relatives will be frozen during this period to prevent insider trading. The specific date for the board meeting to approve these financial results will be communicated separately.